ダポキセチンのグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Dapoxetine Market Insights and Forecast to 2028

• レポートコード：QY2203B04017
• 出版社/出版日：QYResearch / 2022年3月
• レポート形態：英文、PDF、113ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥686,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,029,000 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,372,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界のダポキセチンの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にダポキセチンの世界市場のxxx％を占める「30mg」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「オフラインチャンネル」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国のダポキセチンの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのダポキセチン市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのダポキセチン市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

ダポキセチンのグローバル主要メーカーには、Johnson & Johnson、Menarini、Hetero Healthcare、Sun Pharmaceuticals、Emcure Pharmaceuticals、Kelun Pharmaceutical、HUaPont Pharma、Hicin Pharmaceutical、Huiyinbi Group、Sino Pharma、Kinhoo Pharmaceutical、Salubris、Lancom、Lianhuan Group、Northeast Pharmaceutical、Guangzhou Baiyunshan Pharmaなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

ダポキセチン市場は、種類と用途によって区分されます。世界のダポキセチン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
30mg、60mg

【用途別セグメント】
オフラインチャンネル、オンラインチャンネル

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- ダポキセチン製品概要
- 種類別市場（30mg、60mg）
- 用途別市場（オフラインチャンネル、オンラインチャンネル）
- 調査の目的
・エグゼクティブサマリー
- 世界のダポキセチン販売量予測2017-2028
- 世界のダポキセチン売上予測2017-2028
- ダポキセチンの地域別販売量
- ダポキセチンの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別ダポキセチン販売量
- 主要メーカー別ダポキセチン売上
- 主要メーカー別ダポキセチン価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（30mg、60mg）
- ダポキセチンの種類別販売量
- ダポキセチンの種類別売上
- ダポキセチンの種類別価格
・用途別市場規模（オフラインチャンネル、オンラインチャンネル）
- ダポキセチンの用途別販売量
- ダポキセチンの用途別売上
- ダポキセチンの用途別価格
・北米市場
- 北米のダポキセチン市場規模（種類別、用途別）
- 主要国別のダポキセチン市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのダポキセチン市場規模（種類別、用途別）
- 主要国別のダポキセチン市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のダポキセチン市場規模（種類別、用途別）
- 主要国別のダポキセチン市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のダポキセチン市場規模（種類別、用途別）
- 主要国別のダポキセチン市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのダポキセチン市場規模（種類別、用途別）
- 主要国別のダポキセチン市場規模（トルコ、サウジアラビア）
・企業情報
Johnson & Johnson、Menarini、Hetero Healthcare、Sun Pharmaceuticals、Emcure Pharmaceuticals、Kelun Pharmaceutical、HUaPont Pharma、Hicin Pharmaceutical、Huiyinbi Group、Sino Pharma、Kinhoo Pharmaceutical、Salubris、Lancom、Lianhuan Group、Northeast Pharmaceutical、Guangzhou Baiyunshan Pharma
・産業チェーン及び販売チャネル分析
- ダポキセチンの産業チェーン分析
- ダポキセチンの原材料
- ダポキセチンの生産プロセス
- ダポキセチンの販売及びマーケティング
- ダポキセチンの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- ダポキセチンの産業動向
- ダポキセチンのマーケットドライバー
- ダポキセチンの課題
- ダポキセチンの阻害要因
・主な調査結果

Dapoxetine, marketed as Priligy, is a medication used for the treatment of premature ejaculation (PE) in men 18–64 years old. Dapoxetine works by inhibiting the serotonin transporter, increasing serotonin’s action at the post synaptic cleft, and as a consequence promoting ejaculatory delay.
Market Analysis and Insights: Global Dapoxetine Market
Due to the COVID-19 pandemic, the global Dapoxetine market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, 30 mg accounting for % of the Dapoxetine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Offline Channel segment is altered to an % CAGR throughout this forecast period.
China Dapoxetine market size is valued at US$ million in 2021, while the US and Europe Dapoxetine are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Dapoxetine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Dapoxetine include Johnson & Johnson, Menarini, Hetero Healthcare, Sun Pharmaceuticals, Emcure Pharmaceuticals, Kelun Pharmaceutical, HUaPont Pharma, Hicin Pharmaceutical and Huiyinbi Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Dapoxetine Scope and Segment
Dapoxetine market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Dapoxetine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
30 mg
60 mg
Segment by Application
Offline Channel
Online Channel
By Company
Johnson & Johnson
Menarini
Hetero Healthcare
Sun Pharmaceuticals
Emcure Pharmaceuticals
Kelun Pharmaceutical
HUaPont Pharma
Hicin Pharmaceutical
Huiyinbi Group
Sino Pharma
Kinhoo Pharmaceutical
Salubris
Lancom
Lianhuan Group
Northeast Pharmaceutical
Guangzhou Baiyunshan Pharma
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Dapoxetine Product Introduction
1.2 Market by Type
1.2.1 Global Dapoxetine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 30 mg
1.2.3 60 mg
1.3 Market by Application
1.3.1 Global Dapoxetine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Offline Channel
1.3.3 Online Channel
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Dapoxetine Sales Estimates and Forecasts 2017-2028
2.2 Global Dapoxetine Revenue Estimates and Forecasts 2017-2028
2.3 Global Dapoxetine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Dapoxetine Sales by Region
2.4.1 Global Dapoxetine Sales by Region (2017-2022)
2.4.2 Global Sales Dapoxetine by Region (2023-2028)
2.5 Global Dapoxetine Revenue by Region
2.5.1 Global Dapoxetine Revenue by Region (2017-2022)
2.5.2 Global Dapoxetine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Dapoxetine Sales by Manufacturers
3.1.1 Global Top Dapoxetine Manufacturers by Sales (2017-2022)
3.1.2 Global Dapoxetine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Dapoxetine in 2021
3.2 Global Dapoxetine Revenue by Manufacturers
3.2.1 Global Dapoxetine Revenue by Manufacturers (2017-2022)
3.2.2 Global Dapoxetine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Dapoxetine Revenue in 2021
3.3 Global Dapoxetine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Dapoxetine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Dapoxetine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Dapoxetine Sales by Type
4.1.1 Global Dapoxetine Historical Sales by Type (2017-2022)
4.1.2 Global Dapoxetine Forecasted Sales by Type (2023-2028)
4.1.3 Global Dapoxetine Sales Market Share by Type (2017-2028)
4.2 Global Dapoxetine Revenue by Type
4.2.1 Global Dapoxetine Historical Revenue by Type (2017-2022)
4.2.2 Global Dapoxetine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Dapoxetine Revenue Market Share by Type (2017-2028)
4.3 Global Dapoxetine Price by Type
4.3.1 Global Dapoxetine Price by Type (2017-2022)
4.3.2 Global Dapoxetine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Dapoxetine Sales by Application
5.1.1 Global Dapoxetine Historical Sales by Application (2017-2022)
5.1.2 Global Dapoxetine Forecasted Sales by Application (2023-2028)
5.1.3 Global Dapoxetine Sales Market Share by Application (2017-2028)
5.2 Global Dapoxetine Revenue by Application
5.2.1 Global Dapoxetine Historical Revenue by Application (2017-2022)
5.2.2 Global Dapoxetine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Dapoxetine Revenue Market Share by Application (2017-2028)
5.3 Global Dapoxetine Price by Application
5.3.1 Global Dapoxetine Price by Application (2017-2022)
5.3.2 Global Dapoxetine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Dapoxetine Market Size by Type
6.1.1 North America Dapoxetine Sales by Type (2017-2028)
6.1.2 North America Dapoxetine Revenue by Type (2017-2028)
6.2 North America Dapoxetine Market Size by Application
6.2.1 North America Dapoxetine Sales by Application (2017-2028)
6.2.2 North America Dapoxetine Revenue by Application (2017-2028)
6.3 North America Dapoxetine Market Size by Country
6.3.1 North America Dapoxetine Sales by Country (2017-2028)
6.3.2 North America Dapoxetine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Dapoxetine Market Size by Type
7.1.1 Europe Dapoxetine Sales by Type (2017-2028)
7.1.2 Europe Dapoxetine Revenue by Type (2017-2028)
7.2 Europe Dapoxetine Market Size by Application
7.2.1 Europe Dapoxetine Sales by Application (2017-2028)
7.2.2 Europe Dapoxetine Revenue by Application (2017-2028)
7.3 Europe Dapoxetine Market Size by Country
7.3.1 Europe Dapoxetine Sales by Country (2017-2028)
7.3.2 Europe Dapoxetine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Dapoxetine Market Size by Type
8.1.1 Asia Pacific Dapoxetine Sales by Type (2017-2028)
8.1.2 Asia Pacific Dapoxetine Revenue by Type (2017-2028)
8.2 Asia Pacific Dapoxetine Market Size by Application
8.2.1 Asia Pacific Dapoxetine Sales by Application (2017-2028)
8.2.2 Asia Pacific Dapoxetine Revenue by Application (2017-2028)
8.3 Asia Pacific Dapoxetine Market Size by Region
8.3.1 Asia Pacific Dapoxetine Sales by Region (2017-2028)
8.3.2 Asia Pacific Dapoxetine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Dapoxetine Market Size by Type
9.1.1 Latin America Dapoxetine Sales by Type (2017-2028)
9.1.2 Latin America Dapoxetine Revenue by Type (2017-2028)
9.2 Latin America Dapoxetine Market Size by Application
9.2.1 Latin America Dapoxetine Sales by Application (2017-2028)
9.2.2 Latin America Dapoxetine Revenue by Application (2017-2028)
9.3 Latin America Dapoxetine Market Size by Country
9.3.1 Latin America Dapoxetine Sales by Country (2017-2028)
9.3.2 Latin America Dapoxetine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Dapoxetine Market Size by Type
10.1.1 Middle East and Africa Dapoxetine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Dapoxetine Revenue by Type (2017-2028)
10.2 Middle East and Africa Dapoxetine Market Size by Application
10.2.1 Middle East and Africa Dapoxetine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Dapoxetine Revenue by Application (2017-2028)
10.3 Middle East and Africa Dapoxetine Market Size by Country
10.3.1 Middle East and Africa Dapoxetine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Dapoxetine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Corporation Information
11.1.2 Johnson & Johnson Overview
11.1.3 Johnson & Johnson Dapoxetine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Johnson & Johnson Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Johnson & Johnson Recent Developments
11.2 Menarini
11.2.1 Menarini Corporation Information
11.2.2 Menarini Overview
11.2.3 Menarini Dapoxetine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Menarini Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Menarini Recent Developments
11.3 Hetero Healthcare
11.3.1 Hetero Healthcare Corporation Information
11.3.2 Hetero Healthcare Overview
11.3.3 Hetero Healthcare Dapoxetine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Hetero Healthcare Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Hetero Healthcare Recent Developments
11.4 Sun Pharmaceuticals
11.4.1 Sun Pharmaceuticals Corporation Information
11.4.2 Sun Pharmaceuticals Overview
11.4.3 Sun Pharmaceuticals Dapoxetine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Sun Pharmaceuticals Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sun Pharmaceuticals Recent Developments
11.5 Emcure Pharmaceuticals
11.5.1 Emcure Pharmaceuticals Corporation Information
11.5.2 Emcure Pharmaceuticals Overview
11.5.3 Emcure Pharmaceuticals Dapoxetine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Emcure Pharmaceuticals Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Emcure Pharmaceuticals Recent Developments
11.6 Kelun Pharmaceutical
11.6.1 Kelun Pharmaceutical Corporation Information
11.6.2 Kelun Pharmaceutical Overview
11.6.3 Kelun Pharmaceutical Dapoxetine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Kelun Pharmaceutical Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Kelun Pharmaceutical Recent Developments
11.7 HUaPont Pharma
11.7.1 HUaPont Pharma Corporation Information
11.7.2 HUaPont Pharma Overview
11.7.3 HUaPont Pharma Dapoxetine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 HUaPont Pharma Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 HUaPont Pharma Recent Developments
11.8 Hicin Pharmaceutical
11.8.1 Hicin Pharmaceutical Corporation Information
11.8.2 Hicin Pharmaceutical Overview
11.8.3 Hicin Pharmaceutical Dapoxetine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Hicin Pharmaceutical Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Hicin Pharmaceutical Recent Developments
11.9 Huiyinbi Group
11.9.1 Huiyinbi Group Corporation Information
11.9.2 Huiyinbi Group Overview
11.9.3 Huiyinbi Group Dapoxetine Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Huiyinbi Group Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Huiyinbi Group Recent Developments
11.10 Sino Pharma
11.10.1 Sino Pharma Corporation Information
11.10.2 Sino Pharma Overview
11.10.3 Sino Pharma Dapoxetine Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Sino Pharma Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Sino Pharma Recent Developments
11.11 Kinhoo Pharmaceutical
11.11.1 Kinhoo Pharmaceutical Corporation Information
11.11.2 Kinhoo Pharmaceutical Overview
11.11.3 Kinhoo Pharmaceutical Dapoxetine Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Kinhoo Pharmaceutical Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Kinhoo Pharmaceutical Recent Developments
11.12 Salubris
11.12.1 Salubris Corporation Information
11.12.2 Salubris Overview
11.12.3 Salubris Dapoxetine Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Salubris Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Salubris Recent Developments
11.13 Lancom
11.13.1 Lancom Corporation Information
11.13.2 Lancom Overview
11.13.3 Lancom Dapoxetine Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Lancom Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Lancom Recent Developments
11.14 Lianhuan Group
11.14.1 Lianhuan Group Corporation Information
11.14.2 Lianhuan Group Overview
11.14.3 Lianhuan Group Dapoxetine Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Lianhuan Group Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Lianhuan Group Recent Developments
11.15 Northeast Pharmaceutical
11.15.1 Northeast Pharmaceutical Corporation Information
11.15.2 Northeast Pharmaceutical Overview
11.15.3 Northeast Pharmaceutical Dapoxetine Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Northeast Pharmaceutical Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Northeast Pharmaceutical Recent Developments
11.16 Guangzhou Baiyunshan Pharma
11.16.1 Guangzhou Baiyunshan Pharma Corporation Information
11.16.2 Guangzhou Baiyunshan Pharma Overview
11.16.3 Guangzhou Baiyunshan Pharma Dapoxetine Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Guangzhou Baiyunshan Pharma Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Guangzhou Baiyunshan Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Dapoxetine Industry Chain Analysis
12.2 Dapoxetine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Dapoxetine Production Mode & Process
12.4 Dapoxetine Sales and Marketing
12.4.1 Dapoxetine Sales Channels
12.4.2 Dapoxetine Distributors
12.5 Dapoxetine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Dapoxetine Industry Trends
13.2 Dapoxetine Market Drivers
13.3 Dapoxetine Market Challenges
13.4 Dapoxetine Market Restraints
14 Key Findings in The Global Dapoxetine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Dapoxetine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 30 mg
Table 3. Major Manufacturers of 60 mg
Table 4. Global Dapoxetine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Dapoxetine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Dapoxetine Sales by Region (2017-2022) & (K Units)
Table 7. Global Dapoxetine Sales Market Share by Region (2017-2022)
Table 8. Global Dapoxetine Sales by Region (2023-2028) & (K Units)
Table 9. Global Dapoxetine Sales Market Share by Region (2023-2028)
Table 10. Global Dapoxetine Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Dapoxetine Revenue Market Share by Region (2017-2022)
Table 12. Global Dapoxetine Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Dapoxetine Revenue Market Share by Region (2023-2028)
Table 14. Global Dapoxetine Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Dapoxetine Sales Share by Manufacturers (2017-2022)
Table 16. Global Dapoxetine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Dapoxetine Revenue Share by Manufacturers (2017-2022)
Table 18. Dapoxetine Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Dapoxetine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Dapoxetine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dapoxetine as of 2021)
Table 21. Dapoxetine Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Dapoxetine Product Offered
Table 23. Date of Manufacturers Enter into Dapoxetine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Dapoxetine Sales by Type (2017-2022) & (K Units)
Table 26. Global Dapoxetine Sales by Type (2023-2028) & (K Units)
Table 27. Global Dapoxetine Sales Share by Type (2017-2022)
Table 28. Global Dapoxetine Sales Share by Type (2023-2028)
Table 29. Global Dapoxetine Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Dapoxetine Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Dapoxetine Revenue Share by Type (2017-2022)
Table 32. Global Dapoxetine Revenue Share by Type (2023-2028)
Table 33. Dapoxetine Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Dapoxetine Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Dapoxetine Sales by Application (2017-2022) & (K Units)
Table 36. Global Dapoxetine Sales by Application (2023-2028) & (K Units)
Table 37. Global Dapoxetine Sales Share by Application (2017-2022)
Table 38. Global Dapoxetine Sales Share by Application (2023-2028)
Table 39. Global Dapoxetine Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Dapoxetine Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Dapoxetine Revenue Share by Application (2017-2022)
Table 42. Global Dapoxetine Revenue Share by Application (2023-2028)
Table 43. Dapoxetine Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Dapoxetine Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Dapoxetine Sales by Type (2017-2022) & (K Units)
Table 46. North America Dapoxetine Sales by Type (2023-2028) & (K Units)
Table 47. North America Dapoxetine Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Dapoxetine Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Dapoxetine Sales by Application (2017-2022) & (K Units)
Table 50. North America Dapoxetine Sales by Application (2023-2028) & (K Units)
Table 51. North America Dapoxetine Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Dapoxetine Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Dapoxetine Sales by Country (2017-2022) & (K Units)
Table 54. North America Dapoxetine Sales by Country (2023-2028) & (K Units)
Table 55. North America Dapoxetine Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Dapoxetine Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Dapoxetine Sales by Type (2017-2022) & (K Units)
Table 58. Europe Dapoxetine Sales by Type (2023-2028) & (K Units)
Table 59. Europe Dapoxetine Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Dapoxetine Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Dapoxetine Sales by Application (2017-2022) & (K Units)
Table 62. Europe Dapoxetine Sales by Application (2023-2028) & (K Units)
Table 63. Europe Dapoxetine Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Dapoxetine Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Dapoxetine Sales by Country (2017-2022) & (K Units)
Table 66. Europe Dapoxetine Sales by Country (2023-2028) & (K Units)
Table 67. Europe Dapoxetine Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Dapoxetine Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Dapoxetine Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Dapoxetine Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Dapoxetine Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Dapoxetine Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Dapoxetine Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Dapoxetine Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Dapoxetine Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Dapoxetine Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Dapoxetine Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Dapoxetine Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Dapoxetine Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Dapoxetine Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Dapoxetine Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Dapoxetine Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Dapoxetine Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Dapoxetine Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Dapoxetine Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Dapoxetine Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Dapoxetine Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Dapoxetine Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Dapoxetine Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Dapoxetine Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Dapoxetine Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Dapoxetine Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Dapoxetine Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Dapoxetine Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Dapoxetine Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Dapoxetine Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Dapoxetine Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Dapoxetine Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Dapoxetine Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Dapoxetine Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Dapoxetine Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Dapoxetine Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Dapoxetine Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Dapoxetine Revenue by Country (2023-2028) & (US$ Million)
Table 105. Johnson & Johnson Corporation Information
Table 106. Johnson & Johnson Description and Major Businesses
Table 107. Johnson & Johnson Dapoxetine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Johnson & Johnson Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Johnson & Johnson Recent Developments
Table 110. Menarini Corporation Information
Table 111. Menarini Description and Major Businesses
Table 112. Menarini Dapoxetine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. Menarini Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Menarini Recent Developments
Table 115. Hetero Healthcare Corporation Information
Table 116. Hetero Healthcare Description and Major Businesses
Table 117. Hetero Healthcare Dapoxetine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. Hetero Healthcare Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Hetero Healthcare Recent Developments
Table 120. Sun Pharmaceuticals Corporation Information
Table 121. Sun Pharmaceuticals Description and Major Businesses
Table 122. Sun Pharmaceuticals Dapoxetine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. Sun Pharmaceuticals Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Sun Pharmaceuticals Recent Developments
Table 125. Emcure Pharmaceuticals Corporation Information
Table 126. Emcure Pharmaceuticals Description and Major Businesses
Table 127. Emcure Pharmaceuticals Dapoxetine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. Emcure Pharmaceuticals Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Emcure Pharmaceuticals Recent Developments
Table 130. Kelun Pharmaceutical Corporation Information
Table 131. Kelun Pharmaceutical Description and Major Businesses
Table 132. Kelun Pharmaceutical Dapoxetine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. Kelun Pharmaceutical Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Kelun Pharmaceutical Recent Developments
Table 135. HUaPont Pharma Corporation Information
Table 136. HUaPont Pharma Description and Major Businesses
Table 137. HUaPont Pharma Dapoxetine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. HUaPont Pharma Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. HUaPont Pharma Recent Developments
Table 140. Hicin Pharmaceutical Corporation Information
Table 141. Hicin Pharmaceutical Description and Major Businesses
Table 142. Hicin Pharmaceutical Dapoxetine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 143. Hicin Pharmaceutical Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Hicin Pharmaceutical Recent Developments
Table 145. Huiyinbi Group Corporation Information
Table 146. Huiyinbi Group Description and Major Businesses
Table 147. Huiyinbi Group Dapoxetine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 148. Huiyinbi Group Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Huiyinbi Group Recent Developments
Table 150. Sino Pharma Corporation Information
Table 151. Sino Pharma Description and Major Businesses
Table 152. Sino Pharma Dapoxetine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 153. Sino Pharma Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Sino Pharma Recent Developments
Table 155. Kinhoo Pharmaceutical Corporation Information
Table 156. Kinhoo Pharmaceutical Description and Major Businesses
Table 157. Kinhoo Pharmaceutical Dapoxetine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 158. Kinhoo Pharmaceutical Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Kinhoo Pharmaceutical Recent Developments
Table 160. Salubris Corporation Information
Table 161. Salubris Description and Major Businesses
Table 162. Salubris Dapoxetine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 163. Salubris Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Salubris Recent Developments
Table 165. Lancom Corporation Information
Table 166. Lancom Description and Major Businesses
Table 167. Lancom Dapoxetine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 168. Lancom Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Lancom Recent Developments
Table 170. Lianhuan Group Corporation Information
Table 171. Lianhuan Group Description and Major Businesses
Table 172. Lianhuan Group Dapoxetine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 173. Lianhuan Group Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. Lianhuan Group Recent Developments
Table 175. Northeast Pharmaceutical Corporation Information
Table 176. Northeast Pharmaceutical Description and Major Businesses
Table 177. Northeast Pharmaceutical Dapoxetine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 178. Northeast Pharmaceutical Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. Northeast Pharmaceutical Recent Developments
Table 180. Guangzhou Baiyunshan Pharma Corporation Information
Table 181. Guangzhou Baiyunshan Pharma Description and Major Businesses
Table 182. Guangzhou Baiyunshan Pharma Dapoxetine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 183. Guangzhou Baiyunshan Pharma Dapoxetine Product Model Numbers, Pictures, Descriptions and Specifications
Table 184. Guangzhou Baiyunshan Pharma Recent Developments
Table 185. Key Raw Materials Lists
Table 186. Raw Materials Key Suppliers Lists
Table 187. Dapoxetine Distributors List
Table 188. Dapoxetine Customers List
Table 189. Dapoxetine Market Trends
Table 190. Dapoxetine Market Drivers
Table 191. Dapoxetine Market Challenges
Table 192. Dapoxetine Market Restraints
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Dapoxetine Product Picture
Figure 3. Global Dapoxetine Market Share by Type in 2021 & 2028
Figure 3. 30 mg Product Picture
Figure 4. 60 mg Product Picture
Figure 5. Global Dapoxetine Market Share by Application in 2021 & 2028
Figure 6. Offline Channel
Figure 7. Online Channel
Figure 8. Dapoxetine Report Years Considered
Figure 9. Global Dapoxetine Sales 2017-2028 (K Units)
Figure 10. Global Dapoxetine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Dapoxetine Revenue 2017-2028 (US$ Million)
Figure 12. Global Dapoxetine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Dapoxetine Sales Market Share by Region (2017-2022)
Figure 14. Global Dapoxetine Sales Market Share by Region (2023-2028)
Figure 15. North America Dapoxetine Sales YoY (2017-2028) & (K Units)
Figure 16. North America Dapoxetine Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe Dapoxetine Sales YoY (2017-2028) & (K Units)
Figure 18. Europe Dapoxetine Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific Dapoxetine Sales YoY (2017-2028) & (K Units)
Figure 20. Asia-Pacific Dapoxetine Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America Dapoxetine Sales YoY (2017-2028) & (K Units)
Figure 22. Latin America Dapoxetine Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa Dapoxetine Sales YoY (2017-2028) & (K Units)
Figure 24. Middle East & Africa Dapoxetine Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The Dapoxetine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of Dapoxetine in the World: Market Share by Dapoxetine Revenue in 2021
Figure 27. Global Dapoxetine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global Dapoxetine Sales Market Share by Type (2017-2028)
Figure 29. Global Dapoxetine Revenue Market Share by Type (2017-2028)
Figure 30. Global Dapoxetine Sales Market Share by Application (2017-2028)
Figure 31. Global Dapoxetine Revenue Market Share by Application (2017-2028)
Figure 32. North America Dapoxetine Sales Market Share by Type (2017-2028)
Figure 33. North America Dapoxetine Revenue Market Share by Type (2017-2028)
Figure 34. North America Dapoxetine Sales Market Share by Application (2017-2028)
Figure 35. North America Dapoxetine Revenue Market Share by Application (2017-2028)
Figure 36. North America Dapoxetine Sales Share by Country (2017-2028)
Figure 37. North America Dapoxetine Revenue Share by Country (2017-2028)
Figure 38. U.S. Dapoxetine Revenue (2017-2028) & (US$ Million)
Figure 39. Canada Dapoxetine Revenue (2017-2028) & (US$ Million)
Figure 40. Europe Dapoxetine Sales Market Share by Type (2017-2028)
Figure 41. Europe Dapoxetine Revenue Market Share by Type (2017-2028)
Figure 42. Europe Dapoxetine Sales Market Share by Application (2017-2028)
Figure 43. Europe Dapoxetine Revenue Market Share by Application (2017-2028)
Figure 44. Europe Dapoxetine Sales Share by Country (2017-2028)
Figure 45. Europe Dapoxetine Revenue Share by Country (2017-2028)
Figure 46. Germany Dapoxetine Revenue (2017-2028) & (US$ Million)
Figure 47. France Dapoxetine Revenue (2017-2028) & (US$ Million)
Figure 48. U.K. Dapoxetine Revenue (2017-2028) & (US$ Million)
Figure 49. Italy Dapoxetine Revenue (2017-2028) & (US$ Million)
Figure 50. Russia Dapoxetine Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific Dapoxetine Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific Dapoxetine Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pacific Dapoxetine Sales Market Share by Application (2017-2028)
Figure 54. Asia Pacific Dapoxetine Revenue Market Share by Application (2017-2028)
Figure 55. Asia Pacific Dapoxetine Sales Share by Region (2017-2028)
Figure 56. Asia Pacific Dapoxetine Revenue Share by Region (2017-2028)
Figure 57. China Dapoxetine Revenue (2017-2028) & (US$ Million)
Figure 58. Japan Dapoxetine Revenue (2017-2028) & (US$ Million)
Figure 59. South Korea Dapoxetine Revenue (2017-2028) & (US$ Million)
Figure 60. India Dapoxetine Revenue (2017-2028) & (US$ Million)
Figure 61. Australia Dapoxetine Revenue (2017-2028) & (US$ Million)
Figure 62. Taiwan Dapoxetine Revenue (2017-2028) & (US$ Million)
Figure 63. Indonesia Dapoxetine Revenue (2017-2028) & (US$ Million)
Figure 64. Thailand Dapoxetine Revenue (2017-2028) & (US$ Million)
Figure 65. Malaysia Dapoxetine Revenue (2017-2028) & (US$ Million)
Figure 66. Philippines Dapoxetine Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Dapoxetine Sales Market Share by Type (2017-2028)
Figure 68. Latin America Dapoxetine Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Dapoxetine Sales Market Share by Application (2017-2028)
Figure 70. Latin America Dapoxetine Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Dapoxetine Sales Share by Country (2017-2028)
Figure 72. Latin America Dapoxetine Revenue Share by Country (2017-2028)
Figure 73. Mexico Dapoxetine Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Dapoxetine Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Dapoxetine Revenue (2017-2028) & (US$ Million)
Figure 76. Middle East and Africa Dapoxetine Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Dapoxetine Revenue Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Dapoxetine Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Dapoxetine Revenue Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Dapoxetine Sales Share by Country (2017-2028)
Figure 81. Middle East and Africa Dapoxetine Revenue Share by Country (2017-2028)
Figure 82. Turkey Dapoxetine Revenue (2017-2028) & (US$ Million)
Figure 83. Saudi Arabia Dapoxetine Revenue (2017-2028) & (US$ Million)
Figure 84. UAE Dapoxetine Revenue (2017-2028) & (US$ Million)
Figure 85. Dapoxetine Value Chain
Figure 86. Dapoxetine Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed

以下、関連資料のご紹介

ダポキセチン塩酸塩のグローバル市場 2021年：企業別、地域別、種類・用途別

Global Dapoxetine Hydrochloride Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-203B16117 2021年12月 86Pages
ダポキセチン塩酸塩市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。...

医薬品物理試験のグローバル市場インサイト・予測（～2028年）

Global Pharmaceutical Physical Testing Market Insights, Forecast to 2028
QY2203B07425 2022年3月 98Pages
新型コロナウイルス感染症のパンデミックにより、世界の医薬品物理試験の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に医薬品物理試験の世界市...

過活動膀胱（OAB）治療のグローバル市場インサイト・予測（～2028年）

Global Overactive Bladder Treatment Market Insights and Forecast to 2028
QY2203B08096 2022年3月 91Pages
新型コロナウイルス感染症のパンデミックにより、世界の過活動膀胱（OAB）治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に過活動膀胱（...

注射用デヒドロアンドログラポライドコハク酸カリウムのグローバル市場インサイト・予測（～2028年）

Global Potassium Dehydroandrograpolide Succinate for Injection Market Insights, Forecast to 2028
QY2203B12151 2022年3月 94Pages
新型コロナウイルス感染症のパンデミックにより、世界の注射用デヒドロアンドログラポライドコハク酸カリウムの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると...

ジプラシドンAPIのグローバル市場インサイト・予測（～2028年）

Global Ziprasidone API Market Insights, Forecast to 2028
QY2203B03172 2022年3月 76Pages
新型コロナウイルス感染症のパンデミックにより、世界のジプラシドンAPIの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にジプラシドンAPI...

抗毒素血清のグローバル市場インサイト・予測（～2028年）

Global Antivenom Serum Market Insights and Forecast to 2028
QY2203B09229 2022年3月 97Pages
新型コロナウイルス感染症のパンデミックにより、世界の抗毒素血清の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に抗毒素血清の世界市場のxx...

4-ブロモ-2-フルオロフェノールのグローバル市場インサイト・予測（～2028年）

Global 3-Bromo-2-Fluorophenol Market Insights, Forecast to 2028
QY2203B00311 2022年3月 113Pages
新型コロナウイルス感染症のパンデミックにより、世界の4-ブロモ-2-フルオロフェノールの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に4...

ソタロールのグローバル市場インサイト・予測（～2028年）

Global Sotalol Market Insights and Forecast to 2028
QY2203B03860 2022年3月 94Pages
新型コロナウイルス感染症のパンデミックにより、世界のソタロールの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にソタロールの世界市場のxx...

2-プロピルペンタン酸ナトリウムのグローバル市場インサイト・予測（～2028年）

Global Sodium 2-Propylpentanoate Market Insights, Forecast to 2028
QY2203B00157 2022年3月 88Pages
新型コロナウイルス感染症のパンデミックにより、世界の2-プロピルペンタン酸ナトリウムの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に2-...

インテグリンα4のグローバル市場インサイト・予測（～2028年）

Global Integrin Alpha 4 Market Insights and Forecast to 2028
QY2203B01685 2022年3月 114Pages
新型コロナウイルス感染症のパンデミックにより、世界のインテグリンα4の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にインテグリンα4の世...

ダポキセチン塩酸塩のグローバル市場 2021年：企業別、地域別、種類・用途別 The Dapoxetine Hydrochloride market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
インスリン様成長因子のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Insulin Like Growth Factor Market Due to the COVID-19 pandemic, the global Insulin Like Growth Factor market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. F…
海水浴用おもちゃのグローバル市場インサイト・予測（～2028年） Beach Toys are toys for children to play on the beach. Market Analysis and Insights: Global Beach Toys Market Due to the COVID-19 pandemic, the global Beach Toys market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % duri…
パンクレリパーゼのグローバル市場インサイト・予測（～2028年） Pancrelipase (CAS 53608-75-6) is a combination of three enzymes (proteins): lipase, protease, and amylase. These enzymes are normally produced by the pancreas and are important in the digestion of fats, proteins, and sugars. Pancrelipase is used to replace these enzymes when the body does not have e…
フルシトシン錠のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Flucytosine Tablets Market Due to the COVID-19 pandemic, the global Flucytosine Tablets market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully consideri…